Public Profile

Acs Dobfar Spa

Acs Dobfar Spa, headquartered in Italy, is a prominent player in the pharmaceutical and healthcare industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1972, the company has established a strong presence in Europe and beyond, with a commitment to innovation and excellence. With a diverse portfolio that includes both sterile and non-sterile products, Acs Dobfar Spa stands out for its advanced production technologies and stringent quality control measures. The company has achieved significant milestones, including certifications from major regulatory bodies, which underscore its dedication to safety and efficacy. Recognised for its market leadership, Acs Dobfar Spa continues to expand its reach, providing tailored solutions that meet the evolving needs of the pharmaceutical sector.

DitchCarbon Score

How does Acs Dobfar Spa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Acs Dobfar Spa's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Acs Dobfar Spa's reported carbon emissions

As of the latest available data, ACS Dobfar S.p.A., headquartered in Italy, has not reported any specific carbon emissions figures for the most recent year. However, the company is committed to achieving net-zero emissions across all scopes by 2050, as part of its long-term climate strategy. This commitment was formalised in 2023, aligning with the Science Based Targets initiative (SBTi). ACS Dobfar's climate initiatives reflect a proactive approach within the pharmaceuticals, biotechnology, and life sciences sector. The company has pledged to implement strategies that will significantly reduce its carbon footprint, although specific reduction targets have not been disclosed. The commitment to net-zero emissions indicates a comprehensive strategy that encompasses all scopes of emissions, including Scope 1, 2, and 3. In summary, while ACS Dobfar has not provided recent emissions data, its commitment to net-zero emissions by 2050 demonstrates a strong dedication to addressing climate change and reducing its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Acs Dobfar Spa's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Acs Dobfar Spa is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Acs Dobfar Spa is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Shenzhen Haibin Pharmaceutical Co. Ltd

CN
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Savior Lifetec Corporation

TW
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Aurobindo Pharma

IN
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers